We are live on ! Find out more
CYTK icon

Cytokinetics

122 hedge funds and large institutions have $380M invested in Cytokinetics in 2018 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 46 increasing their positions, 34 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 34

22% more capital invested

Capital invested by funds: $311M → $380M (+$69.1M)

1.52% more ownership

Funds ownership: 69.19%70.71% (+1.5%)

5% more call options, than puts

Call options by funds: $917K | Put options by funds: $875K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

3% less funds holding

Funds holding: 126122 (-4)

18% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 17

Holders
122
Holders Change
-4
Holders Change %
-3.17%
% of All Funds
2.79%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
14
Increased
46
Reduced
34
Closed
17
Calls
$917K
Puts
$875K
Net Calls
+$42K
Net Calls Change
+$182K
Name Holding Trade Value Shares
Change
Change in
Stake
Comerica Bank
51
Comerica Bank
Texas
$380K -$4.18K -521 -1%
Group One Trading
52
Group One Trading
Illinois
$367K -$156K -19,442 -34%
AIG
53
American International Group
New York
$366K +$9.18K +1,144 +3%
Thrivent Financial for Lutherans
54
Thrivent Financial for Lutherans
Minnesota
$350K +$4.62K +576 +2%
PP
55
PDT Partners
New York
$349K -$77K -9,595 -21%
Public Sector Pension Investment Board (PSP Investments)
56
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$347K +$23.6K +2,937 +9%
TPSF
57
Texas Permanent School Fund
Texas
$339K +$12K +1,492 +5%
Manulife (Manufacturers Life Insurance)
58
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$323K -$38.2K -4,765 -13%
State of Tennessee, Department of Treasury
59
State of Tennessee, Department of Treasury
Tennessee
$323K -$14.7K -1,832 -5%
Two Sigma Investments
60
Two Sigma Investments
New York
$316K -$279K -34,768 -52%
Citigroup
61
Citigroup
New York
$309K -$730 -91 -0.3%
State of Wisconsin Investment Board
62
State of Wisconsin Investment Board
Wisconsin
$295K
ProShare Advisors
63
ProShare Advisors
Maryland
$288K -$9.61K -1,197 -4%
Wells Fargo
64
Wells Fargo
California
$277K +$15.5K +1,931 +7%
UBS AM
65
UBS AM
Illinois
$258K
State Board of Administration of Florida Retirement System
66
State Board of Administration of Florida Retirement System
Florida
$251K
LSERS
67
Louisiana State Employees Retirement System
Louisiana
$237K +$10.4K +1,300 +6%
KeyBank National Association
68
KeyBank National Association
Ohio
$215K -$51.8K -6,453 -23%
WMSA
69
Weiss Multi-Strategy Advisers
New York
$198K +$762 +95 +0.5%
VOYA Investment Management
70
VOYA Investment Management
Georgia
$197K
MIM
71
MetLife Investment Management
New Jersey
$184K
GIA
72
Granite Investment Advisors
New Hampshire
$182K
CS
73
Credit Suisse
Switzerland
$175K -$108K -13,407 -43%
SOADOR
74
State of Alaska Department of Revenue
Alaska
$164K +$2.57K +320 +2%
MSA
75
Mason Street Advisors
Wisconsin
$159K +$11.8K +1,474 +10%

CYTK Hedge Fund Activity: Q3 2018 in Review

122 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q3 2018, worth a combined $380M — up 22% from $311M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of CYTK and 14 opened new positions — a net loss of 3 holders — while 34 trimmed existing stakes and 46 added.

The largest buyer was BlackRock, adding an estimated $6.05M. The largest seller was BVF Inc, cutting an estimated $2.92M.

  • 122 institutional investors held Cytokinetics (CYTK) as of Q3 2018, down from 126 in Q2 2018.
  • Funds reported $380M of Cytokinetics stock for Q3 2018, up 22% quarter-over-quarter.
  • 14 funds opened new Cytokinetics positions in Q3 2018 and 17 closed out, a net change of -3 holders.
  • The largest Cytokinetics buyer in Q3 2018 was BlackRock, an estimated $6.05M added.
  • The largest Cytokinetics seller in Q3 2018 was BVF Inc, an estimated $2.92M sold.

Based on aggregated 13F filings for Q3 2018.